Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with the use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the DRD2 receptor. This evidence concerns the gene AKT1 and psychotic disorder.